|
FR3049951A1
|
|
NOVEL PEPTIDE CONSTRUCTS AND THEIR USE IN THE TREATMENT OF TOXOPLASMOSIS
|
|
FR3048971A1
|
|
BISPECIFIC PEPTIDE CONSTRUCTS AND THEIR USE IN THE TREATMENT OF DISEASES, IN PARTICULAR IMFLAMMATORY DISEASES
|
|
FR3017728A1
|
|
METHOD OF CLASSIFYING AND IDENTIFYING MORPHOESPECES
|
|
WO2014125369A2
|
|
Stable compositions comprising 60bp repeat-deleted gallid herpesvirus-2 (gahv-2)
|
|
FR3015881A1
|
|
PROCESS FOR QUANTIFYING AT LEAST ONE PARAMETER REPRESENTATIVE OF A SUB-EPIDERMAL HYPOECHOGENIC BAND
|
|
FR3013956A1
|
|
IN VIVO EVALUATION METHOD OF THE PHYSIOPATHOLOGICAL STATE OF BIOLOGICAL TISSUE AND ASSOCIATED DEVICE
|
|
FR3010919A1
|
|
METHOD FOR DEPOSITING AN INORGANIC MATERIAL ON A SUBSTRATE, IN PARTICULAR TEXTURED AT THE MICRON OR SUBMICRON SCALE
|
|
FR3008408A1
|
|
NOVEL ANTIBODY-MEDICAMENT CONJUGATES AND THEIR USE IN THERAPY
|
|
FR2932388A1
|
|
NOVEL FUSION PROTEINS AND THEIR APPLICATION FOR THE PREPARATION OF VACCINES AGAINST HEPATITIS C
|
|
FR2923053A1
|
|
METHOD AND DEVICE FOR IMPROVING THE RESOLUTION OF AN ULTRASONIC IMAGE
|
|
WO2005123947A1
|
|
Methods of assessing susceptibility to drug-induced thrombocytopenia
|
|
FR2857452A1
|
|
AUTISM SCREENING TEST, PATIENT SELECTION METHOD FOR TESTING AND USE OF BKCA CHANNEL ACTIVATING MEDICINES FOR THE TREATMENT OF SAID DISEASE
|
|
EP0292525A1
|
|
Biological treatment method by using ultrasound, particularly for immuno-hematological tests
|
|
EP0123594A1
|
|
Endoscopic probe for viewing and ultrasonic scanning echography
|
